Cells treated with the compound (right) showed reduced infection from the Omicron variant compared to untreated cells (left).
(Photo credit: Dr. Selvarani Vimalanathan, Molecular Biomedicine)
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
The findings, published this week in Molecular Biomedicine, reveal a potential path toward antiviral treatments that could be used against many different pathogens.
“Beyond COVID-19, there are many different types of coronaviruses that can cause serious and sometimes fatal disease, and even more are likely to emerge in the future,” says Dr. Yossef Av-Gay, an infectious disease professor in UBC’s faculty of medicine and the study’s senior author.
“We’re working toward treatments that can be broadly effective against all types of coronaviruses so that we can respond to not only current health challenges, but also future pandemic threats. Identifying this compound and the pathway by which it works to stop viruses is an important step in that direction.”
Targeting the host, not the virus
The researchers credit the compound’s broad effectiveness to the unique way it works. Rather than targeting the virus itself, the compound targets a human cellular process that coronaviruses use to replicate.
Since viruses can’t reproduce on their own, they rely on protein-synthesis pathways in host cells to create copies of themselves. In the case of coronaviruses, they use a human enzyme called GSK3 beta that exists in all human cells.
“We found that coronaviruses hijack this human enzyme and use it to edit the protein that packs its genetic material,” says Dr. Tirosh Shapira, a postdoctoral fellow at UBC’s faculty of medicine and the study’s first author. “This compound blocks GSK3 beta, which in turn, stops the virus from reproducing and maturing its proteins.”
The compound is part of a broader family of experimental drugs known as GSK3 inhibitors. Since the late 1990s, scientists across academia and industry have been studying GSK3 inhibitors for their potential as treatments for a number of diseases, including diabetes, Alzheimer’s and cancer.
“By targeting this cellular pathway, rather than the virus itself, we see broad activity against multiple pathogens. We’re also acting on a pathway that is so far immune to changes between variants and different coronaviruses,” says Dr. Shapira.
To identify the compound, the research team screened a library of nearly 100 known GSK3 inhibitors, provided through a collaboration between UBC and Takeda Pharmaceutical Company in Japan. The compounds were tested in cell and tissue models infected with SARS-CoV-2 and the common cold virus.
The testing yielded multiple GSK3 inhibitors that showed a high level of effectiveness against the coronaviruses and low toxicity to human cells. The leading compound, identified as T-1686568, inhibited both SARS-CoV-2 and the common cold virus, the main criteria the authors used in the search for broad-spectrum protection.
“We’re working toward treatments for all types of coronaviruses so that we can respond to not only current health challenges, but also future pandemic threats.”
Dr. Yosseff Av-Gay
“While these are early days, it’s encouraging to see broad levels of effectiveness in tissue models,” says Dr. Shapira. “Because these compounds require many years of testing and regulatory approval before they can potentially reach patients, we need to be thinking about long-term applications and how this could apply broadly to future viruses and variants.”
The research was conducted at UBC FINDER, a level-3 biocontainment facility at UBC where researchers are working with highly infectious pathogens with an aim to develop future treatments.
“We’re not just fighting SARS-CoV-2, we’re looking ahead at what’s next,” says Dr. Shapira. “We’re focused on identifying future-proof treatments for variants and viruses that emerge down the road and rely on the same cellular mechanisms to grow and infect.”
More from: University of British Columbia
The Latest Updates from Bing News
Go deeper with Bing News on:
- Sanofi's BTK inhibitor readout in chronic hives sets up phase 3 push
In the meantime, it looks like Sanofi has another potential option in the form of a Bruton’s tyrosine kinase (BTK) inhibitor called rilzabrutinib. In data from the 160-person phase 2 RILECSU ...
- Angiotensin-Converting Enzyme Inhibitors Side Effects -- Physiologic and Non-Physiologic Considerations
Hypotension is not a specific side effect with ACE inhibitors; rather, it is a broadening of the physiologic action of these drugs that occurs most commonly when a patient becomes volume contracted.
- Therapeutic Benefits of ACE Inhibitors and Other Antihypertensive Drugs in Patients With Type 2 Diabetes
In the 4 eligible trials (the ABCD trial, the CAPPP, the FACET, and the UKPDS), the total number of participants was 2,180 (1,133 randomized to an ACE inhibitor and ...
- Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Plasma-derived products conferred a risk of inhibitor development that was similar to the risk with recombinant products (adjusted hazard ratio as compared with recombinant products, 0.96 ...
- The Best KV Inhibitor Build In MW3
The KV Inhibitor is one of Call of Duty: Modern Warfare 3's new sniper rifles. This 130 RPM rifle can eliminate targets with a single shot from the upper torso and head, making this a powerful ...
Go deeper with Bing News on:
- Shining A Light Reporter
T.A. Walker is a beloved member of the WPTV family, and for good reason. His infectious personality and unwavering dedication to the community have made him a fan favorite in the Palm Beaches.
- AT&T reveals possible cause of massive cellular outage in US which also hit T-Mobile, Verizon users
AT&T seemed to have experienced the largest number of issues, with nearly 32,000 reports at around 4:30 a.m., according to data from DownDetector, which tracks outages by collating status reports ...
- AT&T outage caused by software update, company says
AT&T says they have "restored wireless service to all our affected customers." A temporary network disruption that affected AT&T customers in the U.S. Thursday was caused by a software update ...
- AT&T cellular service restored after daylong outage; cause still unknown
A cellular outage Thursday hit thousands of AT&T users in the United States, disrupting calls and text messages as well as emergency services in major cities including San Francisco. About 58,000 ...
- The Best Men’s White T-Shirts
When you buy through our links, we may earn a commission. Learn more› A white T-shirt is a blank canvas. Versatile, casual, and classic, it can blend in—or stand out—with just about any ...